Latest filing published 23 Dec 2021 for Sanara MedTech Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
J. Michael Carmena: trading record in brief
J. Michael Carmena, listed as chief executive, appears in our data through filings on Sanara MedTech Inc. shares, published by SEC (Form 4). In total, 13 filings cover trades dated from 21 January 2020 to 22 December 2021.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 23 December 2021: a share grant, in Sanara MedTech Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to J. Michael Carmena
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,549 shares0Common StockSEC:0001493152-21-032400:0
- 546 shares@ US$10.53100.0% of flowCommon StockSEC:0001493152-21-032091:0
2 of 2 declarations
